Patent US4321918A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4321918A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for suppressing immunity to transplants

Assignee: Individual
•
Filing: 1979-10-23
•
Granted: 1982-03-30
•
Expires: 1999-10-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract In order to inhibit rejection of transplants in humans, lymphoctyes are suppressed by limited and closely controlled extracorporeal irradiation of an intensity and duration sufficient to reduce lymphocyte function to from about 10% to about 20% of normal.

Inventors

  • 👤 II William T. Clark

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 10:17
CPC Classifications
A; A61; A61M; A61M1/00; A61M1/36; A61M1/3681

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 62 words
A process for inhibiting immunity to a transplant in a human patient undergoing rejection symptoms which comprises: exchanging the patient's blood through an extracorporeal link, and irradiating the patient's blood while in transit through the link with a transit dose to significantly reduce lymphocyte function but less than that required to significantly diminish the patient's lymphocyte population until the rejection symptoms subside.
Claim 2
Dependent Claim 62 words
A process for inhibiting immunity to a transplant in a human patient undergoing rejection symptoms which comprises: exchanging the patient's blood through an extracorporeal link, and irradiating the patient's blood while in transit through the link with a transit dose to significantly reduce lymphocyte function but less than that required to significantly diminish the patient's lymphocyte population until the rejection symptoms subside.
Claim 3
Dependent Claim 71 words
A process for inhibiting immunity to a transplant in a human patient which comprises suppressing lymphocyte function in the patient's blood by exchanging the blood through an extracorporeal irradiation link, and treating the patient's blood by irradiating the same with X-rays until lymphocyte function is reduced to from about 10% to 20% of normal, wherein the blood is irradiated at a predetermined transit dose as a determined by the formula: ##EQU3##
Claim 4
Dependent Claim 71 words
A process for inhibiting immunity to a transplant in a human patient which comprises suppressing lymphocyte function in the patient's blood by exchanging the blood through an extracorporeal irradiation link, and treating the patient's blood by irradiating the same with X-rays until lymphocyte function is reduced to from about 10% to 20% of normal, wherein the blood is irradiated at a predetermined transit dose as a determined by the formula: ##EQU3##
Claim 5
Dependent Claim 25 words
A process as claimed in claim 2, wherein the total dose is of a predetermined limited extent as determined by the formula: Total Dose=Exchanges×Transit Dose.
Claim 6
Dependent Claim 18 words
A process as claimed in claim 3 wherein the total dose is between 24.4 R to 93.3 R.
Claim 7
Dependent Claim 59 words
A process for inhibiting immunity to a transplant in a human patient which comprises suppressing lymphocyte function in the patient's blood by treating the blood by changing the same through an extracorporeal irradiation link, irradiating the blood with X-rays while in transit through the link with a transit dose of about 31.1 R/min. as determined by the formula: ##EQU4##
Claim 8
Dependent Claim 59 words
A process for inhibiting immunity to a transplant in a human patient which comprises suppressing lymphocyte function in the patient's blood by treating the blood by changing the same through an extracorporeal irradiation link, irradiating the blood with X-rays while in transit through the link with a transit dose of about 31.1 R/min. as determined by the formula: ##EQU4##
Claim 9
Dependent Claim 28 words
A process as claimed in claim 5, wherein the total dose per treatment is from 24.4 R to 93.3 R as determined by the formula: Total Dose=Exchanges×Transit Dose.

References Cited (Backward Citations)

US1683877A Cited
US2992329A Cited
US3929130A Cited
US4061741A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-03-29 1985-09-28 1986-03-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-03-29 1989-09-28 1990-03-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-03-29 1993-09-28 1994-03-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag